Back to media

Targeting Ewing Sarcoma with A Novel RBM39 Degrader: DNA Damage Repair Pathway Effects

Publications
April 1, 2025
info@seedtherapeutics.com
411 Swedeland Rd, Suite 1000,
King of Prussia, PA, 19406
HomeTeamOur PipelineMediaOur ScienceContactReferences
© 2026 Seed Therapeutics. All rights reserved.
Privacy PolicyTerms & ConditionsSite by Bunsen